-
DE
Bone remodeling proteins are endogenous proteins that regulate the continuous process of bone formation and resorption. They are essential for maintaining bone density and overall bone health.
Bone remodeling proteins are endogenous proteins that regulate the continuous process of bone formation and resorption. They are essential for maintaining bone density and overall bone health.
Bone remodeling proteins are a group of signaling molecules and structural proteins that regulate the continuous biological process of bone remodeling. Bone is not a static tissue; it is continuously broken down and rebuilt throughout a person's lifetime. This remodeling process serves to repair microdamage, adapt to mechanical loads, and maintain calcium and phosphate homeostasis.
The process is governed by two key cell types: osteoblasts (bone-forming cells) and osteoclasts (bone-resorbing cells). Bone remodeling proteins coordinate the balance between these two cell types.
The most well-known bone remodeling system is the RANKL/RANK/OPG axis:
Bone morphogenetic proteins (BMPs) are members of the TGF-β superfamily. They stimulate the differentiation of stem cells into osteoblasts and are essential for new bone formation and fracture healing. BMP-2 and BMP-7 are used clinically to support bone regeneration.
Sclerostin and DKK1 are inhibitors of the Wnt signaling pathway, which is critical for osteoblast-mediated bone formation. Elevated sclerostin activity suppresses bone formation and can contribute to bone loss.
Osteocalcin is a non-collagenous protein produced by osteoblasts and is used as a biomarker for the bone formation rate. Osteopontin is involved in the attachment of osteoclasts to the bone surface and regulates bone resorption.
Imbalances in bone remodeling proteins can lead to a variety of conditions:
Bone remodeling proteins serve as important biomarkers in the diagnosis of bone metabolism disorders. Blood and urine tests can measure, for example:
Therapeutically, knowledge of bone remodeling proteins has enabled the development of targeted medications. For example, the monoclonal antibody denosumab inhibits RANKL and thereby reduces bone resorption in osteoporosis.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.